Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis. The study found ...

Cases of tuberculosis (TB) — an illness that kills more people than any other infectious disease — rose in the U.S. during 2022, per the Centers for Disease Control and Prevention (CDC). And some ...

The global tuberculosis drugs market is anticipated to witness massive growth during the forecast period (2021 to 2031). Tuberculosis is a chronic illness that has become a global health concern.

Researchers say more study is needed, but early results suggest the century-old vaccine could become a powerful new tool in ...